{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F99e0333a-5ad1-4c9d-b37e-19bca18bec55","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/99e0333a-5ad1-4c9d-b37e-19bca18bec55\"></iframe>","title":"Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers","description":"Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/8c104f4d-e244-446d-b79b-09735385f84f/j6sp7yRb3vZGZpaZTaxWb1wr.png"}